Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update

Avanos Medical, Inc. (NYSE:AVNS) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 614,500 shares, a growth of 11.3% from the November 15th total of 552,300 shares. Approximately 1.4% of the shares of the stock are sold short. Based on an average daily volume of 254,300 shares, the short-interest ratio is currently 2.4 days.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Institutional Investors Weigh In On Avanos Medical

Several institutional investors and hedge funds have recently modified their holdings of AVNS. Azzad Asset Management Inc. ADV grew its holdings in shares of Avanos Medical by 8.5% during the 2nd quarter. Azzad Asset Management Inc. ADV now owns 28,521 shares of the company’s stock worth $568,000 after acquiring an additional 2,223 shares during the period. Natixis Advisors LLC boosted its position in shares of Avanos Medical by 19.5% during the second quarter. Natixis Advisors LLC now owns 18,878 shares of the company’s stock valued at $376,000 after purchasing an additional 3,077 shares in the last quarter. Paradice Investment Management LLC grew its stake in Avanos Medical by 5.4% in the second quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after purchasing an additional 69,389 shares during the period. Quest Partners LLC bought a new position in Avanos Medical in the second quarter worth $444,000. Finally, American Century Companies Inc. lifted its position in Avanos Medical by 12.1% during the second quarter. American Century Companies Inc. now owns 82,930 shares of the company’s stock valued at $1,652,000 after buying an additional 8,929 shares during the period. 95.17% of the stock is owned by hedge funds and other institutional investors.

Avanos Medical Trading Down 2.5 %

NYSE AVNS opened at $17.97 on Friday. The firm has a market cap of $825.90 million, a PE ratio of 52.85 and a beta of 0.95. Avanos Medical has a 1-year low of $17.39 and a 1-year high of $25.36. The stock has a 50-day moving average of $20.27 and a 200-day moving average of $21.43. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.